As mentioned above, there is a significant overlap of a potential biomarker such as aSyn species, Aß, tau, and miRNA (Sadlon et al. 2019) in many patients with neurodegenerative diseases like AD and PD. This evidence concerns the gene MAPT and Parkinson disease.